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EVOLUTION OF THE INTERNATIONAL LEGAL
NORM: A CASE STUDY OF THE LEGAL REGIME
OVER HUMAN GENOME RESEARCH
T.R. Sivaramjani*
DEMYSTIFY/NG

HUMAN

GENOME

RESEARCH

A 'biorevolution' is taking place around us that has echoed reverberations both
in the world of science and of business. As more and more people come to believe
that the new biotechnologies will transfonn our lives more profoundly than transistors or computers, prudence demands that a realistic assessment be made of the
positive nature of such contributions, the risks inherent in the science, its applications and its commercialisation. This is also a critical time in policy fonnulation.
A good place to begin for understanding the dynamics of this science is the
Human Genome Organisation's (HUGO) project (the HUGP) which is a 15 year, $
3 billion effort to analyse human genetic heritage in its ultimate molecular detail.
This effort is funded by the United States Federal Government. It seems to promise
the best hope (yet) for ultimately defeating diseases long known to be 'inherited' and
diagnosing and presumably preventing other conditions thought to bave subtle links
with genes. That this study of human genetics can be used to harm as well as to help,
is a fact acknowledged by the leaders of this project from the start.l Indeed, this is
seen from the fact that they have made it a point of devoting millions of dollars to
studying ethical, legal and social questions thrown up by the project.
Several European countries have taken steps to prevent the abuse of genetic
data. France, Belgium and Norway all have laws preventing the use of genetic
information by life and medical insurance companies. Civil liberties concerns linked
to the need to keep people's genetic or per:-,onal healt11 information private is t11e
prime mover behind several proposed federal legislations in the United States.2
Problematic though they are, t11enature of iliese developments is such iliat they
may be controlled by deft municipal laws, backed of course by ilie necessary
political will.
But most of the international political flak has bcen taken by ilie Human
Gcnome Diversity Project (not formally linked to the Human Genome Project). This
is a plan to collcct DNA samples systematically from about 500 linguistically
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Medical science has long been aware that there is not just one human map, that
each ethnic community can have slightly different genetic composition that could
be invaluable to medicine (both preventive and therapeutic). But the increasing rate
at which populations are mixing (and losing) their genetic uniqueness has given the
Genome Diversity Project added urgency. This sampling project has become
controversial because of an obvious apathy towards indigenous community rights
and the issue of prior informed consent and towards evolving ways and means of
opportunity the tremendous commercial profits that are likely to result from these
endeavours.
Here we come face to face with the prospect of an international scientific
research project threatening the very sovereignty of nation states, their peoples and
resources. In the process, the rights of the indigenous people with their unique
genetic component also suffers. This project may be viewed as another materialisation
of the phenomenon of transnationalism exacerbating issues of "just" economics and
resource-use in an inherently unjust world. The tremendous commercial concerns
linked with an endeavour of this sort, wherein parts of the genome may be subject
to private ownership and control, is widely viewed by indigenous people as a further
affront to their dignity and autonomy. Thus in the Bejing conference Sami indigenous women from the Nordic countries added their voice to the dozens of
indigenous peoples organisations that have denounced the project as a violation of
their rights.3 Concerns of this sort led the UNESCO to criticise the project's lack of
contact with indigenous groups during its very planning phase.4
Of the fact that the controversy is snowballing, there is no doubt. The
ambiguity to a certain extent lies in the nature of the rights that have been abused.
Thus the definitional discourse on human rights, problematic as it is, provides the
backdrop for an estimate of the nature of the values and rights threatened to be
eroded.
NATURE

OF THE HUMAN RIGHTS

IN QUESTION

By far, the most singular aspect of human rights is its claim to universalism
which continues to remain an elusive and contested concept. Yet the difficulty in
defining and demarcating such rights has in no way diminished its importance in
shaping policy options on nation-states.
Diversity of indigenous cultures fulfils a basic spiritual and psychic need in
giving different subcommunities an identity of their own. A recognition of the
autonomous nature of such people is not problematic in this theoretical background
3
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but such recognition becomes a vexed issue in the context of international relations
stamped with the banner of sovereignty of nation-states.
By and large the nation-state framework has failed to provide a desirable
degree of protection to the indigenous people, be it collective cultural rights or
territorial rights. These peoples have always emphasised their unique cultural
identity on the basis of their diverse spiritual and material experiences often linked
to their traditional territories.
The Human Genome; is on the other hand, one of the primordial elements of
the human being and is responsible for human identity and of its transmission to
descendants.5 It may be agreed thus, that it is this genetic core that gives diverse
indigenous peoples' claim to exclusiveness, a legitimacy. By being the basis of a
cultural identity, this primordial element of the human genome allows them to view
themselves as a people and hence lay claim to a degree of self-determination. Thus
when the cell-line of a particular individual, in an ethnically distinct population is
patented it throws a disturbing light on what can be morally owned and appropriated
by private entities. Indeed, private ownership and control of human genetic materials
would be against fundamental human rights, against the shared principles of
freedom, autonomy and dignity of each single human body. It is concerns of this sort
that prompted the Eurbpean Parliament to vote unanimously on an amendment to
the community directive regarding patenting, stating that the human body or its parts
are not patentable as such.
Religious bodies too have in recent times increasingly been fostering studies
on emerging issues implied by genetic technology.6

CONTROL, OWNERSHIP AND ACCESS TO GENETIC RESOURCES
Amongst the most vocal critics of the Human Genome Diversity Project are
environmentalists and groups in developing countries, who are veterans of earlier
campaigns to challenge the increasing control over the world's food crops exercised
by a relatively small number oflarge and mostly western-based agricultural and seed
companies. Thus concems about collection of human genetic diversity stems
inevitably from similar controversies related to the collection and storage of plant
genetic diversity over the past few decades.
Many of the provisions in the Convention on Biological Diversity adopted at
the Earth Summit in 1992 also addresses (albeit imperfectly) issues related to control
and ownership of genetic resources particularly with regard to indigenous people.
The General Agreement on Tariffs and Trade (GATT) related Intellectual Property
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Agreement (TRIPS) requires that signatory states adopt intellectual property laws
covering both 'microbial materials' and 'plant varieties'. Thus human genetic material
is not specifically excluded.
Patent applications in biotechnology usually involve the deposit of biological
material in 'culture collections' and institutions designed to preserve living mater.
Patent culture depositories arc regulated internationally by The Budapest treaty
administered by The World Intellectual Property Organisation in Geneva. A study
of a list of officially recognised culture depositories for the purpose of patent
procedure shows an overwhelming majority of these (which will also preserve any
human genetic material which is the subject of a patent) to be located in industrialised
countries of the North.
This is the international legal regime that sets the stage for the growing battle
over control, access and ownership over human genetic information, which is
qualitatively different from the one over plant germ plasm.
The unprecedented commercial profits expected from genetic research on
indigenous people is clear from a few instances. Blood samples drawn from the
asthmatic inhabitants of the remote South Atlantic Island of Tristan De Cunha were
sold by researchers to a California based company, which in turn sold rights to its,
as yet unproven, technologies for asthma treatment to German Giant Boehringer
Ingelheim for US $ 70 million? Again, the rights of one gene associated with obesity
were sold for $ 70 million.8 These examples, though an extreme are by no means
unique.
Understandably, indigenous groups are incensed. For these people, the issue
of DNA sampling by Western scientists and the increasing involvement of pharmaceutical corporations bring back disturbing memories of the colonial past. The
people from whose hair, blood and other cells these samples are taken are not likely
to see any part of the profits generated, and many of these people are from
communities whose very physical survival is in question.
That the indigenous peoples of Asia-Africa among others see this as a form of
'biocolonial' aggression is a matter of extreme importance to the efficacy of an
intemationallaw
based on the will of the international community. As recognised
very early on, it is only natural that their hostility towards a colonial past spills over
to events that appear to echo the harrowing past.9
Nothing brings these concerns closer home than the issuance of a patent by the
United States Government to itself on the cell line of an indigenous man of the
Hagahai people from the Papua New Guinean Remote Highlands.
7
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In August 1993, the United States Government applied for US and World
patents on the cell line of a 26-year old Guaymi Indian Woman from Panama. The
claim on the cell line of the Hagahai was followed by patents on the cell line of 2
persons, both from the Solomon Islands. 10
These developments cannot be dismissed as futuristic concerns by us in India.
Till recently the centre for ecological studies at the Indian Institute of Science used
to send blood samples from various groups - including high caste Brahmins, lowcaste Harijans and a hunter-gallerer tribe called Kadar to population geneticists at
Stanford University. But the future supply of such material at present on part of the
centre is unlikely, as the centre is awaiting the Indian Government's policy position
(subsequent to its decision to sign GA TI) on the patentability of human genetic
material. I I
Meanwhile the biodiversity convention obliges signatory states to recognise
the ownership of genetic materials by countries or companies. Germplasm collected
in one country prior to the convention coming into force must be regarded as the
property of the country that now stores the material. Thus the human cell lines of
the concerned people in Panama, Papua, New Guinea and the Solomon Islands
(stored in a culture depositary in the United States) under patent claim by the US
Government are now its legal property. According to some interpretations, the
people and countries involved will now have to pay for access to their donated
human materials and any medical products derived therefrom.12
Thus a nation-state has lost control over the very identity that makes its people
what they are. This threatens accepted notions of sovereignty of states over their
peoples. As John Liddle, Director of the Central Australian Aboriginal Congress
puts itl3
"Over the last 200 years, non-aboriginal people have taken our land, language,
culture, health - and even our children. Now they want to take the genetic
material which makes us aboriginal as well".
VOICING A NEW MORALITY
Indigenous knowledge systems are treasures of enlightening information. The
significance of Art. 8(j) of the Biodiversity Convention lies in the fact that it calls
on countries to protect and promote the use of indigenous knowledge. Thus when
anguished indigenous peoples' voices proclaim that to patent human material is
contrary to their view of nature and of man's place in it, that it violates the integrity

10 RAP! Communique, supra n. 7.
11 K.S. Jayaraman, Gene hunters home in India, Nature 13 (2 May 1996).
12 RAP! Communique, The Patentability
13 Id.

of HunUlll Genetic MateriaL, Jan/Feb. 1994.

140

National Law School Journal

[1997

of life itself and their deepest sense of morl!lity, the world would do well to sit up
and listen ..
A morality, such as this, is tinged with a belief in a force greater than man's.
Such beliefs are decidedly not a recent synthesis, rather it is the articulation of these
that are new. It remains to be seen though, whether such an enunciation of a 'new
morality' will move from the confines of the rhetoric to become the premise of the
emerging international legal order over Human Genome Research.
The Declaration of the Indigenous Peoples of the Western Hemisphere regarding the Human Genome Diversity Project, 1995 by indigenous peoples groups of
North, Central and South America may be categorised as a source of material for
norms that demand to be respected in the present. Although by title the declarations
are confined to a limited geographical area, spiritually and materially it finds an echo
in the anguish of indigenous peoples allover the world.
The declaration begins with a recognition of their responsibility as indigenous
peoples to ensure continuity of the natural order of all life to be maintained for
generations to come. It draws a distinction between i:1digenous and non-indigenous
forces which have accompanied colonisation and recognises in the latter's intentions
- an agenda to appropriate and manipulate the natural order for purposes of profit,
power and control. In a decisive stance, the declaration rejects all programmes
involving genetic technology, particularly the Genome Diversity Project, as an
absolute violation of the principles of creation and the identity of each life form in
that natural order.
Most significantly, the. declaration echoes the peoples deepest morality when
it holds that no life can be bought, sold, discovered or patented, even in its smallest
form. The resistance to the idea that human matter can be appropriated and
controlled by private interests is a primordial instinct in man that seeks to protect
the dignity of human life. The morality that finds articulation in this declaration is
one that cannot be easily brushed aside. Ethics, in the sense of moral action, should
come into play in regulating all aspects of such research into the Human Genome
and its subsequent commercialisation. Considering humanity's stakes, any ethical
exercise will have to be at an international level. Indeed, recent developments show
a tendency to incorporate the hitherto evanescent notion of respect for life and the
natural order of things as a value that needs to be respected here and now, rather than
an ideal to be achieved at some later point of time.

FORMULATION OF AN INTERNATIONAL LEGAL RESPONSE
Several Pacific nations are said to be contemplating asking the UN General
Assembly to seek an advisory ruling on the morality of human gene patents from
the International Court of Justice. The ultimate goal of such a move could be to
persuade governments to introduce tighter restrictions on human genetic material in
the GATT related Intellectual Property provisions which are due for review in 1999.
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As it is, the European patent convention allows moral issues to be used to judge
eligibility for patentability.14 This should be a precedent for similar moves on a
global scale.
A group of countries in the South Pacific have drawn up proposals for
implementation of a "LifeformsPatent Free Pacific Treaty" .15As early as in October
1993, the European Greens introduced an emergency resolution in the European
Parliament against human patenting and urged a halt to the Genome Diversity
Project.
In this backdrop, of great significance is The UNESCO Declaration on the
Human Genome, the draft of which was issued in February 1996. This is the second
revised draft on the UNESCO's proposed declaration on The Human Genome and
the Protection of Human Rights and Dignity.
The draft declaration begins with an affirmation that the human genome is a
fundamental componeut of the common heritage of humanity and needs to be
protected in order to safeguard the integrity of the human species, as a value in itself;
as also the dignity and rights of each of its members. No aim of research on the
human genome, it seeks to make clear, can even be contrary to respect for human
dignity and freedom. Although the proposed draft declaration outline does not
respond to private ownership and control of human genetic materials in such terms,
it seeks to disburse a right to 'everyone' to benefit from such technological advances,
with due regard to human dignity and freedom.
In urging the states to adopt normative measures to meet the purposes of the
declaration, it seeks to make them duty-bound to promote and ensure that such
principles are nationally and internationally recognised and effectively applied.
Although a declaration of this sort is perilously close to being consigned as mere
rhetoric in the face of more formidable treaties, it is nonetheless an acknowledgement
of the problematic nature of genome research. In terms of the limited extent of the
non-judicial aspects of international law , this is no mean achievement.
CONCLUSION
In the particular context of Human Genome Research, a moral change· is
becoming perceptible in the increasingly vocal formulation of a different set of
beliefs. This set of beliefs draws its lifeblood from a source different from the strictly
eurocentric, rationalist secular one. The acceptance of these beliefs as an international ethical norm is by no means complete. Yet it is on an inevitable evolutionary
track using the operational structures and processes of international law itself. As
biotechnological advances change the way man perceives reality and his place in it,
it is imperative that international law responds to these with a sense of urgency.
Anything less would be unfortunate.
14 Dickson, supra n. 8.
15 RAF! Communique, supra n. 7.

